Prescription drug · ANDA
Baclofen NDC 50090-6868
Baclofen 10 mg/1 · Tablet · Oral · A-S Medication Solutions
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 50090-6868-0 | 50090686800 | 60 TABLET in 1 BOTTLE (50090-6868-0)Marketed from Dec 4, 2023 | |
| 50090-6868-1 | 50090686801 | 30 TABLET in 1 BOTTLE (50090-6868-1)Marketed from Dec 4, 2023 | |
| 50090-6868-3 | 50090686803 | 90 TABLET in 1 BOTTLE (50090-6868-3)Marketed from Dec 4, 2023 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Baclofen
- Generic name (nonproprietary)
- baclofen
- Active ingredients
- Baclofen — 10 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- A-S Medication Solutions
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 074584
- Marketing start
- Listing expires
- Other FDA classes
- GABA A Agonists (Mechanism)GABA B Agonists (Mechanism)
- Identifiers
- Product ID 50090-6868_c472fde4-c4d2-4ae7-978a-469fbc5ebe2eSPL ID c472fde4-c4d2-4ae7-978a-469fbc5ebe2eSPL set ID 081d478a-2f3f-456e-bcca-00487589da6fRxCUI 197391UNII H789N3FKE8
- Pharmacologic class
- gamma-Aminobutyric Acid-ergic Agonist
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N450090686800followed by a unit qualifier and the quantityPackage 50090-6868-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Baclofen tablets, USP are useful for the alleviation of signs and symptoms of spasticity resulting from multiple sclerosis, particularly for the relief of flexor spasms and concomitant pain, clonus, and muscular rigidity. Patients should have reversible spasticity so that baclofen treatment will aid in restoring residual function. Baclofen tablets, USP may also be of some value in patients with spinal cord injuries and other spinal cord diseases. Baclofen tablets, USP are not indicated in the treatment of skeletal muscle spasm resulting from rheumatic disorders. The efficacy of baclofen in stroke, cerebral palsy, and Parkinson's disease has not been established and, the…
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 074584
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Baclofen | Baclofen 10 mg/1 | TabletOral | Upsher-Smith Laboratories, LLC | 0832-1054 |
| Baclofen | Baclofen 20 mg/1 | TabletOral | Upsher-Smith Laboratories, LLC | 0832-1055 |
| Baclofen | Baclofen 10 mg/1 | TabletOral | A-S Medication Solutions | 50090-6869 |